Harry Hendrikse

PROF.DR., (Principal Investigator)

Full Professor, CCA - Cancer biology and immunology
Full Professor, CCA - Imaging and biomarkers
Physician, Radiology and nuclear medicine

https://orcid.org/0000-0001-8072-5391

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

89 Article
9 Meeting Abstract
6 Review article
4 Letter
More

Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging
van de Stadt, E. A., Yaqub, M., Lammertsma, A. A., Poot, A. J., Schuit, R. C., Remmelzwaal, S., Schwarte, L. A., Smit, E. F., Hendrikse, H. & Bahce, I., 1 May 2021, In: Lung Cancer. 155, p. 156-162
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
van Groen, B. D., Krekels, E. H. J., Mooij, M. G., van Duijn, E., Vaes, W. H. J., Windhorst, A. D., van Rosmalen, J., Hartman, S. J. F., Hendrikse, N. H., Koch, B. C. P., Allegaert, K., Tibboel, D., Knibbe, C. A. J. & de Wildt, S. N., 1 Jan 2021, In: Clinical Pharmacology and Therapeutics. 109, 1, p. 140-149 10 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy
Mammatas, L. H., Yaqub, M., Hendrikse, N. H., Hoekstra, O. S., Honeywell, R. J., Schuit, R. C., Meijerink, M. R., Schwarte, L. A., Peters, G. J., Verheul, H. M. W., Lammertsma, A. A. & Menke-van der Houven van Oordt, C. W., 30 Oct 2020, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Research output: Contribution to journal › Article › Academic › peer-review
177Lutetium PSMA-radioligandtherapie bij prostaatkanker
Vis, A. N., Jansen, B. H. E., Bodar, Y. J. L., Nieuwenhuijzen, J. A., Hendrikse, H. N. & Oprea-Lager, D. E., 1 Jul 2020, In: Tijdschrift voor Urologie. 10, 4, p. 60-65 6 p.
Research output: Contribution to journal › Article › Professional

Open Access
ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases
van de Stadt, E. A., Yaqub, M., Bahce, I. & Hendrikse, N. H., 1 Feb 2020, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61, 2, p. 305 1 p.
Research output: Contribution to journal › Letter › Academic › peer-review

Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging

The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study

11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy

177Lutetium PSMA-radioligandtherapie bij prostaatkanker

ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases